• Exchange: OTC US
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

Corgenix Medical Corp

+ Add to Watchlist


0.2670 USD 0.0070 2.55%

As of 10:38:37 ET on 10/31/2014.

Snapshot for Corgenix Medical Corp (CONX)

Open: 0.2775 Day's Range: 0.2661 - 0.2800 Volume: 95,085
Previous Close: 0.2740 52wk Range: 0.1800 - 0.5601 1-Yr Rtn: +27.14%

Stock Chart for CONX

No chart data available.
  • CONX:US 0.2670
  • 1D
  • 1M
  • 1Y
Interactive CONX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CONX

Current P/E Ratio (ttm) 44.5223
Estimated P/E(-) -
Relative P/E vs. SPX 2.5146
Earnings Per Share (ttm) 0.0060
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 14.48
Shares Outstanding (M) 54.23
30 Day Average Volume 609,686
Price/Book (mrq) 2.2751
Price/Sale (ttm) 1.0465
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CONX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CONX

Corgenix researches, develops, manufactures, and markets in vitro diagnostic products for use in clinics, hospitals, and freestanding laboratories worldwide. Corgenix sells various products, including diagnostic test kits for cardiovascular and immunological diseases, and holds the worldwide rights to technology that measures Hyaluronic Acid (HA) in the blood.

Douglass T SimpsonPresident/CEOWilliam H CritchfieldSenior VP:Finance & Ops /CFO
Ann L SteinbargerSenior VP:Sales & Marketing
More Company Profile & Key Executives for CONX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil